Business News

New data show that the vaccine works well against the species found in India

The two BioNTech / Pfizer or Oxford / AstraZeneca Covid-19 products provide better protection against infectious diseases from the original known plants in India, according to new data from the UK, which show a decrease in potency compared to the so-called Kent mutations.

BioNTech / Pfizer jab provided 88% protection against B. 1.617.2 species found in India, a slight decrease from 93% given against B.1.1.7 which was first detected in Kent in southeastern England, according to and a study by Public Health England.

The protection provided by the two Oxford / AstraZeneca vaccines was low against the two types, at 66 percent of B.1.1.7 and 60 percent of B. 1.617.2.

However, officials warned that the numbers could be in short supply, indicating a temporary release of the second AstraZeneca jab measure compared to the BioNTech / Pfizer shoot, which means the AZ team was tracked in the short term.

These figures support hope that the UK government can end the country’s closure as enacted on June 21.

Numerous studies indicate that the AZ vaccine takes several weeks to reach a certain stage, indicating that its immune system may not work properly.

The decrease in strength against B. 1.617.2 was similar to all vaccines: about 6 percent of BioNTech / Pfizer vaccines, and 10% of Oxford / AstraZeneca.

Matt Hancock, secretary of health and social services, described the new evidence as “broken”. Regarding the number of people who have already been vaccinated, he added: “We can be confident that more than 20m people – more than 1 in 3 – have adequate protection against this”, a number that grew by “hundreds of thousands” every day.

Dr Mary Ramsay, chief of the vaccine at Public Health England, said she and her colleagues expected the vaccine to be very effective in preventing hospitalization and death.

The rigidity and versatility of Indian nationalities is crucial to see if Boris Johnson can fulfill his “map” to fully open up the world. Officials report daily to the minister and hold private talks with Hancock and the Prime Minister once a week to change them as Johnson makes his final decision, he said internally.

Saturday’s release explains in more detail the first figures the Financial Times saw.

The available evidence so far suggests that B. 1.617.2 is less likely to evade vaccine protection than B.1.351, the first known species in South Africa, according to health officials.

Data from English hospitals showed that of the 2,889 genetically determined strains of the B virus 1.6 1.617.2, 104 led to the emergency department, of which 31 slept overnight, and 6 died. These records have not yet been fully implemented with the vaccine, so the risk of serious cases among vaccinated and non-vaccinated individuals is unknown.

A special PHE report published on Saturday showed further evidence that B. 1.617.2 is more likely than B.1.1.7.

But examples of British scientists have also shown that the extent to which growth varies widely between different parts of the UK. A health official said in London the rate of change of B.1.1.7 and B. 1.617.2 appears to be substituting for another type without any growth, but in some parts of England the variant first noticed India was growing fast enough to make an increase everything.

Dr Robert Challen, of the University of Exeter, whose Indian species was presented to the scientific community, SAGE, said it was difficult to reach the end of the causes of the diversity. Home size can play a role but “there may be some things that are easier to control such as ventilation or solid buildings”, he added.

Source link

Related Articles

Leave a Reply

Back to top button